PROTOCOL DOCUMENTATION

QUALITY ASSURANCE PROTOCOL

CLASSIFICATION: LEVEL-1 VERIFICATION

OVERVIEW

Every compound produced by Triple Sequence Labs undergoes a rigorous multi-stage verification protocol before release. Our quality assurance pipeline is designed to eliminate uncertainty — each stage acts as an independent gate that a compound must clear before advancing. The result: verified, documented, research-grade material you can trust.

99%+
PURITY
HPLC
VERIFIED
MS
CONFIRMED
COA
PROVIDED
VERIFICATION PIPELINE

MULTI-STAGE QA PROCESS

01
STAGE 01

RAW MATERIAL ASSESSMENT

Incoming amino acids, resins, and reagents are inspected and verified against manufacturer certificates of analysis. Identity, purity, and storage condition compliance are confirmed before any material enters the synthesis pipeline.

PASS → NEXT STAGE
02
STAGE 02

SYNTHESIS VERIFICATION

Solid-phase peptide synthesis (SPPS) is monitored in real-time with coupling efficiency checks at each residue addition. Incomplete couplings trigger repeat cycles or process review to maintain chain fidelity.

PASS → NEXT STAGE
03
STAGE 03

HPLC PURITY ANALYSIS

Reverse-phase high-performance liquid chromatography (RP-HPLC) is performed on every lot to quantify purity. Compounds must demonstrate ≥99% purity by area-under-curve analysis to pass this gate.

PASS → NEXT STAGE
04
STAGE 04

MASS SPECTROMETRY

Electrospray ionization mass spectrometry (ESI-MS) confirms molecular weight and structural identity. Observed mass must match theoretical mass within ±0.1% tolerance to verify successful synthesis.

PASS → NEXT STAGE
05
STAGE 05

ENDOTOXIN SCREENING

Limulus Amebocyte Lysate (LAL) testing is conducted on applicable compounds to screen for bacterial endotoxin contamination. Results are documented and must fall below established thresholds.

PASS → NEXT STAGE
06
STAGE 06

COA GENERATION & RELEASE

All analytical data is compiled into a comprehensive Certificate of Analysis. Only after QA review and sign-off is the lot assigned a release status and made available for fulfillment.

LOT RELEASED
ANALYTICAL METHODS

INSTRUMENTATION & TECHNIQUE

HPLC ANALYSIS

High-Performance Liquid Chromatography

Reverse-phase HPLC is our primary quantitative purity method. Compounds are separated on a C18 column using gradient elution with acetonitrile/water mobile phases containing 0.1% TFA. UV detection at 220 nm provides the chromatographic profile from which purity is calculated by area-under-curve integration.

COLUMNC18 Reverse-Phase
DETECTIONUV @ 220 nm
MOBILE PHASEACN/H₂O + 0.1% TFA
THRESHOLD≥99% AUC
MASS SPECTROMETRY

Electrospray Ionization Mass Spectrometry

ESI-MS is used to confirm the molecular identity of each compound. Electrospray ionization generates multiply-charged ions that are analyzed by a time-of-flight (TOF) or quadrupole mass analyzer. The deconvoluted molecular mass is compared against the theoretical mass to verify synthesis accuracy.

IONIZATIONElectrospray (ESI)
ANALYZERTOF / Quadrupole
OUTPUTDeconvoluted Mass
TOLERANCE±0.1% Observed
DOCUMENTATION

CERTIFICATE OF ANALYSIS

Every lot ships with a comprehensive Certificate of Analysis (COA) that provides full analytical transparency. The COA serves as the definitive quality record for each compound and includes the following data points:

COA DATA FIELDSINCLUDED WITH EVERY LOT
01LOT NUMBER

Unique identifier for complete traceability

02PURITY %

Quantified via RP-HPLC area-under-curve analysis

03HPLC CHROMATOGRAM

Full chromatographic profile of the compound

04MS DATA

Observed vs. theoretical molecular weight confirmation

05APPEARANCE

Visual characterization of lyophilized product

06STORAGE

Recommended storage conditions and shelf life

HANDLING PROTOCOL

STORAGE & RECONSTITUTION

°C
STORAGE

Temperature Control

All lyophilized peptides should be stored at 2-8°C (refrigerated) for short-term use. For long-term storage, maintain at -20°C or below. Avoid repeated freeze-thaw cycles.

FORM

Lyophilized Powder

Compounds are supplied as lyophilized (freeze-dried) powder sealed under inert atmosphere. This form provides maximum stability and shelf life when stored according to protocol.

RECONSTITUTION

Bacteriostatic Water

Reconstitute with bacteriostatic water (0.9% benzyl alcohol) for research use. Inject slowly along the vial wall to avoid foaming. Once reconstituted, store at 2-8°C and use within 30 days.

!
NOTICE — RESEARCH USE ONLY

All products referenced on this page are intended strictly for in-vitro research and laboratory investigation. They are not intended for human or veterinary use, food or cosmetic applications, or any clinical or therapeutic purpose. Quality assurance data is provided for research documentation purposes only.